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Introduction
The basic concept of microarray technology was initiated by the model of Ekins , stating that microspot of elements should be [1 2 ] " " able to detect analytes with a higher sensitivity than conventional immunoassays. On this basis, DNA microarray rapidly became the first application of this model and several well established approaches are now available to monitor mRNA abundance from small amount of materials. However, this approach is biased by the lack of relation between mRNA and proteins abundance, and is not sufficient to understand complex cellular networks. Considerable effort are being undertaken to develop a comparable technology for the analysis of protein levels, modifications and interactions. The development of methods for the global analysis of the protein of the cell is still in its early stage. Currently, the dominant technology for profiling of protein expression is two-dimensional (2D) gel electrophoresis . This [3 ] procedure is time-consuming and expensive and reproducibility is often an issue. There is a challenge to replace gels with alternative methods of protein expression analysis, including microarrays. Three types of protein microarrays are currently used: analytical, functional and reverse phase microarrays . Analytical microarrays are typically used to profile a complex mixture of proteins in order to measure [4 ] binding affinities, specificities and protein expression levels. In this technique, monoclonal antibodies or derived formats such as Fab (Fragment Antigen Binding), scFv (single chain variable Fragment) but also aptamers and affibodies are arrayed on a support and the [5 ] array is probed with a protein solution. Antibody microarrays, pioneered by MacBeath and Schreiber and Haab et al , are the most [6 ] [7 ] common analytical microarray. This type of microarray will provide new means to perform differential protein expression profiling of healthy vs. diseased samples. They are expected to play a key role within disease diagnostics, biomarkers discovery and drug target identification. The ability to monitor multiple protein interactions in parallel has many advantages such as saving of time, cost, sample consumption, especially if assays are miniaturized. Most array-based strategies use sandwich assays that can be highly sensitive and specific, but this design is not compatible with high-density array. A complementary technology is label-based detection, affording high level of multiplexing and high density, at the expense of specificity and sensitivity . [8 ] To perform global proteome analysis, high demands will be placed upon the choice of catcher proteins. The specificity of the probes is also a critical feature since analytes must be specifically detected in heterogeneous mixtures containing more than 10 000 different irrelevant proteins. Currently, mainly low-density antibody microarrays (on planar substrate or on bead) have successfully been designed and developed . In contrast to nucleic acids, antibodies and proteins in general are chemically and structurally much more complex, [9 -13 ] heterogeneous, and often unpredictable regarding their interaction profiles. Therefore, it is difficult to define general protein detection and immobilization strategies that do not discriminate between proteins. It is well accepted that oriented immobilization strategies improve array performances but most described strategies involve multiple steps including purification and are not compatible with [14 -16 ] high-throughput array generation.
Recombinant antibody libraries such as scFv or Fab, providing numerous probes based on a single scaffold with similar biological properties, will display significant advantages. But, recombinant antibody formats such as scFv are often unstable and produced with [17 ] a poor yield. In 1993, Hamers-Casterman et al discovered that serum of camels, dromedaries and llamas contain a unique type of [18 ] antibodies devoid of light chains. Camelids produce functional antibodies devoid of light chains (HCAbs) and CH1 domain, of which the single N-terminal domain is fully capable of antigen binding. When they are recombinantly produced, these single domain antibody fragments (sdAbs) have several advantages for biotechnological applications thanks to their unique properties of size (15 kDa), stability even without disulfide bond formation , solubility, and expression yield . These features should lead to a number of applications [19 ] [ 20 ] where sdAb should outperform other antibody formats, notably as capture molecule for antibody arrays.
In this study, we have generated proof-of-principle for several immobilization strategies of sdAbs contained in crude bacterial lysates, namely immobilization of in vivo biotinylated sdAbs by direct spotting of bacterial lysate on streptavidin, or multi-tagged sdAbs on anti-tag antibodies. By use of these immobilization strategies, we compared different detection methods, either by sandwich or label-based detection. These methods allow the specific and sensitive detection of subnanomolar antigen concentration without using signal amplification in model systems with pure antigen as well as crude patient sera.
Materials and methods

Proteins and serum sample
Anti-HIV-1 Nef sdAb (manuscript in preparation and ) and anti-CEA sdAb were selected from immunized sdAb libraries.
[21 ] [22 ] pET vector were used to produce in vivo biotinylated sdAbs. All sdAbs produced in this vector carry a C-terminal his -tag, with or 6 without Avitag (GLNDIFEAQKIEWHE) upstream. To generate plasmids coding for sdAb-avitag -his , sdAb-tags was first amplified (TCAGCAAGCTTAGGATCCGTGATGATGATGGTGGTGTTCGTGCCATTCGATTTTCTGAGCCTCGAAGATGTCGTTCAGACCTGCGG CCGCTGAGGAGACAG) and seqT7 (TAATACGACTCACTATAGGG). Purified PCR product were digested with NcoI and BamHI and followed by gel purification and ligation into vector pET-sdAbaNef -his which had been previously digested with the same restriction 6 enzymes.
pJF55 vector was used for the production of sdAbs fused to c-myc tag. All sdAbs produced in this vector contain one, three, or no C-terminal myc-tag (EQKLISEEDL) followed by a his -tag. Vector pJF55-trimyc-his was generated by overlapping PCR using primers 6 6 t r i m y c f o r (ACCGTCTCCTCAGCGGCCGCAGAACAGAAACTGATCTCTGAAGAGGACCTGAACGGTGAGCAGAAGCTCATTTCCGAGG) a n d t r i m y c r e v (CGCCAAAACAGAAGCTTTTAGTTGAGGTCCTCTTCGCTGATCAATTTTTGTTCGCCATTCAAATCTTCCTCGGAAATGAGCTTCTG C). Then, the purified PCR product was digested with NotI and HindIII, gel-purified and cloned into vector pJFsdAb-cmyc-his that had 6 been digested with the corresponding restriction enzymes. All constructs were verified by nucleotide sequencing.
Patient sera were kindly provided by Pr. J.H. Cohen, (Universit de Reims Champagne-Ardenne, Reims). Concentration of soluble é CEA in patient sera varied between 150 and 750 ng/ml while CEA negative sera have a concentration of CEA lower than 5 ng/ml.
In vitro Biotinylation
The in vitro biotinylation of protein was performed using Ez-link micro NMHS-PEO4-biotinylation kit (Perbio science) following the recommendation of the manufacturer.
Labeling with Alexa488
The labeling of Nef with Alexa488 was performed using Alexa Fluor 488 Microscale Protein Labeling kit (Invitrogen) following the recommendation of the manufacturer to obtain a degree of labeling (DOL) of Nef of around 3 Alexa per molecule.
Production and purification of sdAbs
Vectors pET and pJF containing different sdAbs were transformed in Bl21DE3 and DH5 strain respectively. Cells containing the α plasmid were inoculated in 10 ml of 2YT medium (bactotryptone 16 g/l, yeast extract 10 g/l, NaCl 85 mM) supplemented with ampiciline (100 g/ml) and glucose (2 ). Cells were grown over night at 37 C (250 rpm). Then cells were diluted to obtain an OD of 0.1 in 400 μ %°6 00 ml of 2YT medium supplemented with ampicillin (100 g/ml) and cultures were grown until the OD reached 0.5, when sdAb expression μ was induced by the addition of 0.1 mM IPTG (isopropyl-h-D-thiogalactopyranoside) at 30 C (250 rpm) for 20 h. For in vivo biotinylated°s dAbs, bacteria were co-transformed with pBir vector (Avidity, Colorado) and the culture medium was supplemented with chloramphenicol (50 g/mL) during production. Fifty M biotin was added during the induction. etermined spectrophotometrically using a protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA).
Production of sdAb-containing crude bacterial lysates
Vectors pET and pJF containing different sdAbs were transformed in BL21DE3 and DH5 strain respectively. Transformed cells 
Flow cytometry analysis
Experiments were performed on ice with rocking in 1 BSA PBS. Typically, 2 10 cells resuspended in 50 l were distributed in various concentrations (500 to 0.00005 nM) of anti-Nef sdAb produced in the cytoplasm or periplasm of bacteria. After three washes with PBS, plates were incubated with 9E10 mAb (against c-myc) (santa cruz biotechnology) (1 g/ml) in 2 MPBS for one hour at RT.
μ %
Following three washes with PBS, a goat anti-mouse HRP-conjugated mAb (Jackson) (0.16 g/ml in 2 MPBS) was incubated for one μ % hour at RT. After three washes in PBS, bound secondary antibodies were detected using ABTS. Coloration was followed at 405 nm.
Immobilization of sdAbs biotinylated
Streptavidin plates (Thermo scientific), streptavidin beads (invitrogen), or nitrocellulose slide (Sciencetec) coated with streptavidin overnight at 4 C (10 g/ml) were blocked with 5 MPBS for two hours at RT. SdAbs were diluted in 50 L of 2 MPBS and incubated°μ
overnight at 4 C in streptavidin plate and in plate containing beads. SdAbs contain in bacterial lysate diluted in 2 MPBS were spotted°¼ % and slides were dried for one hour at RT. Wells and slides were incubated with sample (Nef or serum) in 2 MPBS one hours at RT. After 
Tristar reader (Berthold technologies) and slides with Alexa labeled mAb were read on Odyssey infrared imaging system (Licor).
Immobilization of trimyc-tagged sdAbs
Protein G beads or epoxy beads (Invitrogen), or nitrocellulose slides (Sciencetec) were incubated with 9E10 mAb (anti c-myc mAb, Santa-Cruz, sc-40) (1 g/ml in PBS) 1h at RT for protein G beads, 48h at 4 C for epoxy beads, ON at 4 C for slides and blocked with 5 μ°°% MPBS for two hours at RT. SdAbs, either pure or contained in crude bacterial lysate were diluted in 2 MPBS and incubated for 1h at RT % in plate with containing beads. SdAbs contain in bacterial lysate diluted in 2 MPBS were spotted and slides were dry one hour at RT.
¼ %
After three washes with PBS, plates and slides were incubated with biotinylated Nef in 2 MPBS for one hours at RT. After 3 washes % with PBS, plates were incubated with HRP-conjugated streptavidin (Jackson) (1 g/ml) and slides with Alexa680-conjugated streptavidin μ (Invitrogen) (4 g/ml). Following 3 washes in PBS, ABTS substrate (sigma) was added on plates and color development was followed at μ 405 nm and slides with Alexa labeled streptavidin were read on Odyssey infrared imaging system (Licor).
Results
Domain antibodies can be efficiently expressed in E. coli cytoplasm
Libraries of recombinant antibody fragments are a rich source of capture reagents. However, because they require disulfide bond formation, most fragments such as Fab or scFv fragments are produced in the periplasmic space of E. coli, an oxidizing environment favoring a correct folding of these fragments. In contrast, single domain antibodies are characterized by a very high solubility and stability that should allow them to fold properly in reducing environments such as the E. coli cytoplasm. To check this hypothesis, two model sdAbs (targeting Nef from HIV-1 or human carcinoembryonic antigen (CEA) ) were produced in E. coli fused or not to a signal [21 ] [ 22 ] sequence, and purified from the periplasmic or cytoplasmic extract, respectively, and purified by metal affinity chromatography. As for most sdAbs, high production yields (10 30 mg.L ) were obtained. Gel filtration analysis showed than only monomer format was 
Oriented sdAb immobilization
Beside its efficiency, cytoplasmic sdAb production further offers the possibility to biotinylate sdAbs in vivo using a C-terminal fusion with a 15 amino acids tag (avitag) recognized by the E coli BirA enzyme. The resulting molecules possess a single biotin molecule coupled to a single lysine present on the avitag, which allows a near covalent and oriented immobilization through binding to streptavidin.
In contrast, in vitro biotinylation can lead to inactivation of the protein and does not allow oriented immobilization. To test this hypothesis, the anti-Nef sdAb was fused to the avitag, biotinylated in vivo and purified. For comparison, the anti-Nef sdAb was purified and biotinylated in vitro using a primary amine coupling strategy. Biotinylation efficiency was checked by incubation over streptavidin beads.
Up to 95 of in vivo biotinylated sdAbs and 80 of in vitro biotinylated sdAbs could be captured on beads, demonstrating an efficient % % biotinylation (data not shown). As shown in , the in vivo biotinylated sdAb had to be diluted tenfold compared to the chemically Fig. 2A biotinylated version to yield similar results, suggesting that in vivo biotinylation preserves the activity of the sdAb and allows an optimal orientation.
However, this strategy precludes the use of the streptavidin:biotin system for detection of bound molecules, a useful strategy for high throughput approaches. As an alternative, we decided to immobilize sdAbs via interaction between a c-terminal c-myc tag (EQKLISEEDLN) and mAb 9E10, a commercially available murine IgG binding to this peptidic sequence. Three tandem repetitions of the tag (named trimyc tag) were also fused to the sdAb C-terminus to increase the apparent affinity of the tagged molecule by avidity effect.
As demonstrated by ELISA, ( ), mAb 9E10 bound to protein G beads led to a much better sdAb immobilization, leading in turn to a Fig. 2B much higher capture efficiency of the model antigen. The sdAb bearing the trimyc tag could be diluted by three orders of magnitude compared to the molecule bearing a single c-myc tag to yield similar signals.
Use of crude lysates containing sdAbs
The highly efficiencies reached by these immobilization strategies allow the use of very low concentration of capture sdAbs. We reasoned that the oriented immobilization could be used as a built-in purification procedure, allowing the use of crude bacterial lysates.
Indeed as demonstrated in
, as low as 50 nL of a crude lysate containing the in vivo biotinylated anti-Nef sdAb yielded the same Fig. 3 signal intensity as 1 g/mL of the same purified sdAb on a bead assay, suggesting that a regular microplate sdAb production (30 L) could μ μ be used to generate up to 600 measures. 5 10
Assay Sensitivity
To determine the sensitivity of the trimyc-based assay, beads coupled to 9E10 were incubated with 50 nL of bacterial lysate containing the anti-Nef sdAb fused to the c-myc or the trimyc tag. Beads were subsequently incubated with various concentrations of biotinylated Nef. Bound antigen was detected using streptavidin-HRP.
shows that the trimyc tag yielded much higher signals, leading to the Similar experiments were conducted using the streptavidin/avidin based immobilization strategy and 50 nL of crude bacterial lysate per well. Detection of the bound antigen was performed using three different methods, namely using an anti-Nef mAb followed by a HPR-labeled secondary antibody or an Alexa-labeled secondary antibody, compared to a direct fluorescent labeling of the antigen (Nef-Alexa). As shown in , the indirect labeling strategies yielded the best results, with a detection limit of 0.5 nM for enzymatic Fig. 4C indirect labeling, 5 nM for fluorescent indirect labeling and 50 nM for the fluorescent direct labeling. A detection limit of 0.5 nM was measured on nitrocellulose slides using sandwich fluorescent detection. Streptavidin preincubation of slides further led to a significant decrease of background noise ( ). Fig. 4D 
Application to clinically relevant concentration of cancer biomarker
To demonstrate that these strategies can be applied to high throughput diagnostic approaches, 0.5 L of crude bacterial lysates μ containing in vivo biotinylated anti-CEA sdAbs were used in a bead based assay to detect soluble CEA in serial dilutions of crude cancer patient sera of known CEA concentration. Detection was performed using an enzymatic sandwich assay. As shown in , soluble CEA Fig. 5 could be detected in all CEA-containing sera. The detection limit was established at 10 pM i.e. 2 ng/mL of soluble CEA. This concentration is below the value of circulating CEA in sera of normal donors (~ 5 ng/mL in undiluted serum) and well below concentration of cancer patients (178 769 ng/mL). In this study, we show that highly functional and sensitive arrays could be generated using non-purified affinity tagged single domain antibodies (sdAbs) as probes. These fragments are very easy to produce in E. coli, are compatible with cytoplasmic expression and are extremely stable. sdAbs were produced in 96 well plate format and successfully coupled, enriched and purified in a one-step procedure directly onto the support. Indeed, we demonstrate that extremely low amount, i.e. 0.5 to 0.05 l (probably depending on the sdAb affinity) μ of crude bacterial lysate produced in three hours is sufficient to perform one assay. Such efficiency was achieved using strong and oriented immobilization on slide arrays or beads, through the use of directed cytoplasmic biotinylation of sdAbs for immobilization on streptavidin coated supports or a tandem repetition of the c-myc tag for immobilization on mAb 9E10-coated support. Oriented immobilization based on modified with Ni -ions or streptavidin , , are examples of surface that have been successfully applied to generate
[15 16 26 ] planar protein arrays through specific coupling chemistries. However, to our knowledge, only purified monoclonal antibodies coupled with standard procedure such as carbodiimide and succinimide reactions are currently used for bead arrays.
These two complementary approaches were developed to fulfill two different needs. One hand, high sensitivity and specificity are two crucial parameters for diagnostic arrays. In this case, the most efficient approach is the sandwich assay, using a pair of probes to specifically capture and detect the antigen of interest. In this case, non-purified sdAbs can be efficiently immobilized using the biotin/streptavidin setting, to be used as capturing reagent. This method allowed a subnanomolar limit of detection (LOD) of a pure model antigen Nef using fluorescent and enzymatic detection methods. In a clinical setting, i.e. the detection of circulating CEA in sera of cancer patients, a picomolar LOD of CEA in crude serum was obtained with an enzymatic sandwich detection system. In the case of Nef detection, slides or beads as assay support yielded similar results. Of note, direct labeling of antigen with fluorophore was found very inefficient, and chemical sample biotinylation followed by detection with labeled streptavidin led to much higher signals, as already demonstrated by other studies . Bead assays are especially suited for sandwich assays and can be directly compared to ELISA method [27 ] , while requiring much smaller volumes of sample material. Beads can be coded by using various concentrations of fluorescent dye, or [28 ] by some type of barcoding technology such as size of the bead. Consequently, bead assays can easily be multiplexed. Thus bead arrays are method of choice for low density antibodies array for clinical diagnosis , . In this work we show that magnetic beads can efficiently [29 30 ] be functionalized using a biotin-based sdAb immobilization. This approach would therefore be the method of choice for the development of cost-efficient sandwich-based antibody bead arrays for diagnostic.
On the other hand, and despite its efficiency, the sandwich assay, requiring a pair of specific probe for each antigen, is not compatible with the generation of high density antibody arrays. These approaches most often necessitate sample labeling (i.e serum or cell lysate), being most efficiently performed using chemical biotinylation and labeled streptavidin . For such needs, trimyc-tagged sdAbs were [27 ] developed to similarly achieve strong and oriented immobilization without involving biotin. Very large sdAb libraries can be built in a one step procedure from immunized llamas without being concerned about correct combination of VH and VL domain, and rapidly enriched for specific binder by display techniques. Moreover, sdAbs are very efficiently produced in 96 well plates and thus, they represent a rich source of probe to generate high density arrays in a high throughput fashion. In this work, we demonstrate that high sensitivities in the nanomolar range could be achieved with this setting for our model antigen on beads but also on planar arrays such as nitrocellulose arrays, clearly more adapted to high density arrays, and demonstrating the feasibility of using crude bacterial lysate to immobilize tagged sdAbs on slide in a high throughput screening compatible fashion. This approach can further be used for differential screening (i.e. using normal vs disease samples) of sdAb libraries enriched on disease material, potentially leading to the discovery of new biomarkers. We are currently applying this approach to isolate breast cancer specific sdAbs from libraries built using animals immunized with breast cancer biopsies.
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■ •
E. coli E. coli ▲ Captured antibodies were detected by a mouse anti c-myc mAb followed by a goat anti-mouse HRP-conjugated mAb. Standard deviation represents two experiments performed in triplicates.
Figure 2
In vivo biotinylation and multi tags strongly improve immobilization of sdAbs A) Serial dilutions of pure anti-Nef sdAb biotinylated in vivo ( ), in vitro ( ) or unbiotinylated ( ) were coated on streptavidin plate and
incubated with Nef at 5 nM. The captured antigen was detected with a mouse anti-Nef antibody followed by a goat anti-mouse HRP-conjugated mAb. B) Protein G bead were coated with 1 g/ml of 9E10 mAb. Serial dilutions of pure sdAbs with three ( ), one ( ) or no μ • ■ ( ) myc tag were incubated with the bead, followed by biotinylated Nef at 5 nM. The captured antigen was detected with a HRP-conjugated ▲ streptavidin. Standard deviation represents two experiments performed in triplicates.
Figure 3
Bacterial lysates are a good source of capture antibody Streptavidin beads were coated with sdAb against Nef biotinylated in vivo pure ( ) (1 g/ml) or in bacterial lysate ( ) (50 nl/wells) or sdAb 
Figure 4
In vivo biotinylated and trimyc-tagged sdAbs in bacterial lysate allow a sensitive antigenic detection on slide or beads A) Immobilization of sdAbs using trimyc tag allows the direct use of bacterial lysates. Epoxy bead were coated with 9E10 (1 g/ml) and antigen was detected with a mouse anti-Nef antibody followed by a goat anti-mouse HRP ( , ) or Alexa488-conjugated mAb ( , ). D)
• ■ ▲ ▼ Nitrocellulose slides were incubated with streptavidin (S) or PBS ( ). Bacterial lysates containing sdAbs biotinylated in vivo or Ø unbiotinylated were spotted. Serial dilutions of Nef were incubated and the captured antigen was detected with a mouse anti-Nef antibody followed by a goat anti-mouse Alexa705-conjugated mAb. Standard deviation represents two experiments performed in triplicates.
Figure 5
Immobilization of biotinylated sdAbs allows a sensitive detection of CEA in patient sera using a bead assay in vivo Streptavidin beads were coated with bacterial lysates (0.5 l/wells) containing in vivo biotinylated ( , , , ) or unbiotinylated ( ) anti-CEA μ
• ■ ▼ ▲ ◆ sdAbs and incubated with serial dilutions of patient sera ( : S1 CEA 276 ng/ml, : S2 CEA 769 ng/ml, : S3 CEA 178 ng/ml, : S4 CEA <
• ■ ▲ ▼ 5ng/ml). The captured antigen was detected with a mouse anti-CEA antibody (35A7) followed by a goat anti-mouse HRP-conjugated mAb.
Standard deviation represents two experiments performed in triplicates.
